Site-specific integration as an efficient method for production of recombinant human hyaluronidase PH20 in semi-adherent cells.
Appl Microbiol Biotechnol
; 106(4): 1459-1473, 2022 Feb.
Article
en En
| MEDLINE
| ID: mdl-35107633
PH20 is a hyaluronidase enzyme that can hydrolyze the glycosidic bond in hyaluronic acid as the major proteoglycan found in extracellular matrices. In the present study, we constructed and characterized two donor plasmids, one of them with one and the second with two PH20 expression cassettes. The expression vectors were site specifically integrated into the genome of HEK293T cells using PhiC31 integrase system to develop HEK293T stable cell lines secreting His-tagged recombinant human PH20 (rhPH20) in the culture supernatant. The produced rhPH20 was quantified using ELISA and turbidimetric assay tests, and its catalytic activity was also assessed by treating the mouse cumulus-oocyte complexes. Our results showed that the secreted rhPH20 in the culture supernatant had the specific activity of 16,660 IU/mg and the recombinant enzyme was able to remove the cumulus cells from oocytes. The results also indicated that phiC31 enzyme inserted the PH20-expressing donor vectors into the specific pseudo attP sites including 10q21.2 and 20q11.22 in the genome of the target cells with different copy numbers. Taken together, our findings demonstrate that PhiC31 integrase system is able to be applied as a robust tool for efficient production and secretion of soluble and active rhPH20 by HEK293T cells as a semi-adherent human cell line. KEY POINTS: ⢠Efficient production of human recombinant PH20 in a semi-adherent human cell line ⢠Successful application of PhiC31 integrase system for generation of stable recombinant clones ⢠Use of a human cell line for expression of a recombinant human protein due to complex and efficient post-translational modifications and protein folding.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Bacteriófagos
/
Hialuronoglucosaminidasa
Límite:
Animals
/
Humans
Idioma:
En
Revista:
Appl Microbiol Biotechnol
Año:
2022
Tipo del documento:
Article
País de afiliación:
Irán
Pais de publicación:
Alemania